SUMMER NOEL: Open Payments
NPI 1609437417 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 27 payments from 14 companies in 2025. Trend: 2023 $588 · 2024 $986 · 2025 $592
Food & beverage: $589Education: $4
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $104 |
| Novo Nordisk Inc | 3 | $90 |
| Calliditas Therapeutics US Inc. | 2 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Alexion Pharmaceuticals, Inc. | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $24 |
Products named: KRYSTEXXA, JARDIANCE, TARPEYO, Ozempic, Kerendia, ULTOMIRIS, Wegovy, PREVYMIS.
Industry payments across SC — which companies pay providers there.
